To translate a pharmacovigilance report such as an Individual Case Safety Report (ICSR), you produce an accurate target-language version that preserves the verbatim source description, the MedDRA-coded terms, and the structured case fields, often within a 24-hour reporting window. Regulators including the EMA, FDA, and MHRA require ICSRs in a designated language, and EMA Good Pharmacovigilance Practices (GVP) require either the primary source's verbatim text or an accurate translation of it. Because safety reports arrive as scanned forms, handwritten notes, and non-editable files, a format-preserving translation tool with OCR keeps the case structure intact while meeting the deadline.
Bluente is an AI-powered document translation platform used by 30,000+ professionals to translate files in 120+ languages while preserving original formatting. For drug-safety teams, that means an ICSR, PSUR, or DSUR comes back with its fields, tables, and narrative structure unchanged, ready for review and submission.
What Pharmacovigilance Documents Need Translation?
The documents that most often need translation are Individual Case Safety Reports (ICSRs), Periodic Safety Update Reports (PSURs), Development Safety Update Reports (DSURs), and Risk Management Plans (RMPs), along with the source materials behind them: adverse-event intake forms, patient narratives, and medical records. Each carries strict terminology and formatting expectations, and each feeds a regulated submission.
ICSRs are the highest-volume, highest-pressure category. Companies frequently translate hundreds of reports a day, each averaging around 300 words, against tight deadlines, which makes manual vendor turnaround impractical. The challenge is doing it fast without losing the verbatim source language or the coded terminology that regulators expect.
Why Is Verbatim Accuracy So Critical in Safety Translation?
Verbatim accuracy is critical because EMA GVP guidelines require ICSRs to include either the exact text used by the primary reporter or an accurate translation of it, and any drift in meaning can change how an adverse event is assessed. A patient's description of a symptom, translated loosely, can alter causality assessment, seriousness classification, or signal detection downstream.
This is why generic translation that paraphrases is unsafe for pharmacovigilance. The workflow has to preserve the source meaning precisely and map clinical terms to standardized MedDRA terminology consistently. Bluente reaches up to 95% accuracy on specialized terminology and lets safety teams lock MedDRA terms, product names, and standardized phrasing with a custom glossary, so the same adverse-event term renders the same way across every report.
How Do You Translate Scanned or Handwritten Adverse-Event Reports?
You translate them by first running optical character recognition (OCR) to extract the text from scans, faxes, or handwritten intake forms, then translating while preserving the form layout. ICSRs routinely arrive as non-editable PDFs, photographed forms, or handwritten notes, which is why OCR is a core part of the workflow rather than an optional extra.
Bluente handles scanned PDFs and images (PNG, JPG, TIFF) with built-in OCR, translating the extracted content while keeping the original form structure. A two-column case form or a tabular lab-result sheet comes back with its layout intact, so reviewers can compare source and target side by side without rebuilding the document.
Can AI Translation Meet the 24-Hour Reporting Deadline?
Yes. Because Bluente translates most documents in under 2 minutes and supports batch processing, safety teams can clear a high-volume queue of ICSRs well inside the 24-hour expedited-reporting window. The bottleneck in safety translation is rarely the language itself; it is the turnaround time and the manual reformatting that follows a flattened translation.
By removing the reformatting step entirely (the translated report keeps its structure automatically) and running many reports in a single pass, the platform turns a same-day deadline from a scramble into routine throughput. The AI handles the volume; your pharmacovigilance reviewers spend their time on the cases that need judgment, not on retyping forms.
Is It Compliant and Secure Enough for Patient Data?
Yes. Pharmacovigilance documents contain sensitive personal and health data, and Bluente is SOC 2 Type II, GDPR, and ISO 27001 compliant, with zero data retention, automatic deletion within 24 hours, and end-to-end encryption. Your documents are never used to train any AI model.
For life-sciences teams operating under GxP expectations and data-privacy obligations, this is non-negotiable. The platform's zero-retention posture means patient narratives and case details are translated and then purged, never stored or reused, which is exactly what a drug-safety compliance review requires.
How Does This Fit a Global Safety Operation?
It fits because regulators worldwide enforce comparable standards: alongside the EMA, FDA, and MHRA, agencies such as Japan's PMDA and Health Canada require high-quality safety translation, so a single platform covering 120+ languages consolidates what would otherwise be many regional vendors. A global safety database receives cases in dozens of source languages and must report in the designated language for each authority.
Centralizing translation on one secure, format-preserving platform gives consistency that a patchwork of agencies cannot: the same glossary, the same MedDRA mapping, and the same structure rules apply whether the source case is in Japanese, German, or Portuguese.
What About Aggregate Reports Like PSURs and DSURs?
Aggregate safety reports such as PSURs, DSURs, and RMPs are larger and more table-heavy than single ICSRs, which makes format preservation even more important when translating them. These documents pull together line listings, summary tabulations, and signal-evaluation tables that lose their meaning the moment columns shift or rows detach from their headers.
Bluente keeps those tables and their numbering intact, so a translated PSUR reads as a faithful copy of the source rather than a reconstruction. Combined with the same glossary used for ICSRs, the terminology stays consistent from the individual case all the way up to the aggregate report, which is exactly the continuity that reviewers and inspectors expect to see across a safety dossier.
Frequently Asked Questions
Q: Does the EMA require ICSRs to be translated verbatim? EMA GVP guidelines require an ICSR to include either the verbatim text from the primary source or an accurate translation of it. Preserving the source meaning precisely, rather than paraphrasing, is essential.
Q: How fast can ICSRs be translated to meet expedited reporting? Bluente translates most documents in under 2 minutes and processes reports in batches, which lets safety teams meet the 24-hour expedited-reporting deadline even at high volume.
Q: Can it handle handwritten or scanned safety reports? Yes. Built-in OCR extracts text from scanned PDFs, faxes, photographed forms, and images, then translates while preserving the form layout.
Q: How is MedDRA terminology kept consistent? A custom glossary locks MedDRA-coded terms, product names, and standardized phrasing so adverse-event terminology translates identically across every report and language.
Q: Is patient data safe on the platform? Yes. Bluente has zero data retention, deletes documents within 24 hours, encrypts end to end, never trains on your data, and is SOC 2 Type II, GDPR, and ISO 27001 compliant.
Q: Which regulators' requirements does this support? The workflow supports EMA, FDA, and MHRA expectations and extends to other authorities such as PMDA and Health Canada, with 120+ languages covered on one platform.
Start translating documents for free. Bluente preserves your formatting across 120+ languages in under 2 minutes. Try BluTranslate free — no credit card required.